» Articles » PMID: 32201519

FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells Through Repressing MiR-100-5p and MiR-125b-5p

Overview
Journal J Cancer
Specialty Oncology
Date 2020 Mar 24
PMID 32201519
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

: Nasopharyngeal carcinoma (NPC) is a unique subtype of head and neck cancer, within highest incidence in South China and southeastern Asia but rare in other regions worldwide. FOXA1 is a pioneer factor implicated in various human malignancies. Downregulation of FOXA1 promotes NPC cells proliferation, invasiveness in vitro and tumorigenicity in vivo. However, it is remain elusive to determine whether microRNAs (miRNAs) regulated by FOXA1 contribute to NPC progression. : In this study, differentially expressed miRNAs and mRNAs induced by FOXA1 expression were determined by microarray. Integrative miRNA-mRNA regulatory networks mediated by FOXA1 in NPC were established. The expressions of differentially expressed miRNAs in NPC cells were measured by quantitative reverse-transcription PCR. Cell viability was determined by CCK-8 assays. Cell migration and invasiveness were measured by Transwell assays. The correlation between miRNAs and its target mRNAs was analyzed. : FOXA1 suppressed the expression of miR-100-5p and miR-125b-5p in NPC cells. Silencing either miR-100-5p or miR-125b-5p inhibited the malignant behaviors of NPC cells, whereas re-expression of miR-100-5p or miR-125b-5p restored the malignancy of NPC cells repressed by FOXA1. Mechanistically, miR-100-5p or miR-125b-5p suppressed RASGRP3 or FOXN3 expression respectively via direct binding to its 3'-UTR. Furthermore, we demonstrated that FOXA1 induced RASGRP3 or FOXN3 expression via inhibiting miR-100-5p or miR-125b-5p. Upregulation of RASGRP3 or FOXN3 contributed to inhibition of NPC by FOXA1. We also demonstrated that the mRNA levels of RASGRP3 and FOXN3 are positively correlated with FOXA1. : Our study provided evidence the first time that FOXA1 suppresses NPC cells via downregulation of miR-100-5p or miR-125b-5p.

Citing Articles

miR‑100: A key tumor suppressor regulatory factor in human malignant tumors (Review).

Zhang L, Zhang J, Zhang X, Liu S, Qi C, Gao S Int J Mol Med. 2025; 55(4).

PMID: 40017111 PMC: 11875724. DOI: 10.3892/ijmm.2025.5508.


Foxa1 disruption enhances human cell integration in human-mouse interspecies chimeras.

Wang L, Jia J, Yang X, Wen Y, Liu J, Li D Cell Tissue Res. 2024; 399(2):231-245.

PMID: 39708115 DOI: 10.1007/s00441-024-03941-3.


FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma.

Ge J, Liu Y, Chen P, Zeng Z, Li G, Xiong W J Immunother Cancer. 2024; 12(11).

PMID: 39542656 PMC: 11575282. DOI: 10.1136/jitc-2024-010091.


An ontology-based knowledge graph for representing interactions involving RNA molecules.

Cavalleri E, Cabri A, Soto-Gomez M, Bonfitto S, Perlasca P, Gliozzo J Sci Data. 2024; 11(1):906.

PMID: 39174566 PMC: 11341713. DOI: 10.1038/s41597-024-03673-7.


Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia.

Karabay A, Ozkan T, Karadag Gurel A, Koc A, Hekmatshoar Y, Sunguroglu A Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9701-9721.

PMID: 38916832 PMC: 11582232. DOI: 10.1007/s00210-024-03198-1.


References
1.
Li J, Wang W, Chen S, Cai J, Ban Y, Peng Q . FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma. Cancer Lett. 2018; 442:1-14. DOI: 10.1016/j.canlet.2018.10.036. View

2.
Orso F, Quirico L, Dettori D, Coppo R, Virga F, Ferreira L . Role of miRNAs in tumor and endothelial cell interactions during tumor progression. Semin Cancer Biol. 2019; 60:214-224. DOI: 10.1016/j.semcancer.2019.07.024. View

3.
Chen Y, Chan A, Le Q, Blanchard P, Sun Y, Ma J . Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64-80. DOI: 10.1016/S0140-6736(19)30956-0. View

4.
Cirillo L, Lin F, Cuesta I, Friedman D, Jarnik M, Zaret K . Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell. 2002; 9(2):279-89. DOI: 10.1016/s1097-2765(02)00459-8. View

5.
Qiu W, Xia X, Qiu Z, Guo M, Yang Z . RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway. Gene. 2017; 633:35-41. DOI: 10.1016/j.gene.2017.08.024. View